Latest News about AZN
Recent news which mentions AZN
AstraZeneca COVID-19 Jab Shows 74% Efficacy In US Trial
September 30, 2021
From Benzinga
AstraZeneca vaccine shows 74% efficacy in large U.S.-backed trial, and BioNTech co-founder says COVID will become manageable
September 30, 2021
From MarketWatch
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
NIH-Backed US Study Of Mixed COVID-19 Vaccines Regime To Conclude Soon: CNBC
September 29, 2021
From Benzinga
Why AstraZeneca And Pfizer Shares Are Moving Today
September 29, 2021
From Benzinga
AstraZeneca and ASML lead European stocks on a rebound after Wall-Street induced rout
September 29, 2021
From MarketWatch
Can These Former Biotech Growth Stocks Regain Their Form?
September 29, 2021
From Motley Fool
Adagio's COVID-19 Candidate Shows Prolonged Half-Life, Neutralization At Six Months
September 29, 2021
From Benzinga
AstraZeneca Buys Fortress-Biotech Founded Caelum For $500M
September 29, 2021
From Benzinga
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
From Benzinga
Does This Biotech Have the Secret to Conquering Covid Variants?
September 29, 2021
From Motley Fool
AstraZeneca's Saphnelo For Lupus Treatment Approved In Japan
September 28, 2021
From Benzinga
AstraZeneca, Sputnik Light COVID-19 Vaccine Mix Shows Strong Antibody Growth: Reuters
September 27, 2021
From Benzinga
Novavax and the Changing Covid-19 Vaccine Game
September 27, 2021
From InvestorPlace
James Bond and Rolls Royce fight to keep London stocks in the black
September 27, 2021
From MarketWatch
3 Biotech Stocks That Could Make You Filthy Rich
September 27, 2021
From Motley Fool
10 Biggest Price Target Changes For Monday
September 27, 2021
From Benzinga
Get ready for growth stocks to come roaring back to life says this top-performing manager. Here are his picks.
September 27, 2021
From MarketWatch
3 Top Biotech Stocks to Buy for the Long Haul
September 27, 2021
From Motley Fool
Why AstraZeneca Stock Is Trading Higher Today
September 24, 2021
From Benzinga
Sinovac's COVID-19 Vaccine Shows Efficacy, But Lags Rivals In Malaysian Study: Reuters
September 24, 2021
From Benzinga
AstraZeneca - Merck's Lynparza Delays Disease Progression In Prostate Cancer Patients
September 24, 2021
From Benzinga
4 Stocks to Buy for Protection From an Evergrande-Driven Correction
September 23, 2021
From InvestorPlace
RedHill Settles Movantik Patent Litigation With Aurobindo
September 23, 2021
From Benzinga
AstraZeneca Invests In Imperial College's Self-Amplifying RNA Tech
September 23, 2021
From Benzinga
Why Corvus Pharmaceuticals Stock Is Down Today
September 22, 2021
From Motley Fool
AstraZeneca To Inject $360M In Irish API Manufacturing Site
September 21, 2021
From Benzinga
Here's Why Everyone's Talking About AstraZeneca Right Now
September 21, 2021
From Motley Fool
Why AstraZeneca and Surface Oncology Rose Today
September 20, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.